Maria Rullan

[Nacho Vallejo #cambiahospital @ivmaroto_nacho]

"Con las personas adecuadas podrías tener un hospital en un bosque (o en un desierto), pero sin sanitarios, el mejor hospital del mundo no es mucho más que un hotel"
Un hospital no es una churrería. Sobre la editorial del @bmj_latest
https://t.co/naKxbf2P95
#cambiahospital

[Ignacio Fernández-Urién @FernandezUrien]

Last Wednesday, we started the online training course on capsule endoscopy, with the participation of 110 employees from @medtronic representing 19 different countries. Delighted to provide them with the opportunity to delve deeper into the technique.

#OwlEyesAcademy #Medtronic

[Daniel Oyón @daniel_oyon]

BILEMUT approach in indeterminate biliary strictures after first ERCP vs current clinical practice approach:
- ⬇️costs without impairing diagnostic accuracy
- ⬇️ the time and number of diagnostic tests to achieve a final diagnosis.
- ⬇️ theoretical risk of complications.
@my_ueg

[EURO-CHOLANGIO-NET @CholangioNet]

The highlight of the conference today were the discussion panels. Keeping in mind that behind all science there is always the real focus: the patient! @curecc @CharityAMMF

[EURO-CHOLANGIO-NET @CholangioNet]

Are you a clinician evaluating patients with suspected perihilar #cholangiocarcinoma? 🧑‍⚕️
If so, please take a few minutes (3-5 mins) to participate to this @cholangionet-supported survey on clinical staging in pCCA.
✍️ learn more and fill in the survey: https://t.co/4i05bn2g2m

[Daniel Oyón @daniel_oyon]

Clinical Practice Guidelines on the management of Intrahepatic Cholangiocarcinoma #IntrahepaticCholangiocarcinoma
@EASLedu

[Gut Journal @Gut_BMJ]

#GUTImage from the commentary by Morita and Duda on

"Refining genetic and molecular classifications to facilitate breakthrough treatments in intrahepatic cholangiocarcinoma: are we there yet?" via

https://t.co/wdaameoYOZ

#CCa #Cholangiocarcinoma

[Arndt Vogel @ArndtVogel]

🔥Great news: Imfinzi + CisGem approved in the EU as first #immunotherapy regimen for patients with advanced biliary tract cancer
👉TOPAZ-1 phs-III: CisGem + Durva
✅New SOC for #biliarytractcancer
🤔Still room for improvement❗️
@myESMO @OncoAlert @EASLedu #LiverTwitter
@CcaEns

[Gut Journal @Gut_BMJ]

Included (in no particular order) as a #GUTTopPaper chosen by @emadelomar is

"Next-generation sequencing of bile cell-free DNA for the early detection of patients with malignant biliary strictures" via https://t.co/r41tPUIeNC

@Areche_M, @MaiteGF_B, @BarcenaVarela, @CIMA_unav

[María Arechederra @Areche_M]

WOW!!! Our work has been selected as a #GUTTopPaper 🤗!!!! Many thanks @Gut_BMJ and @emadelomar for including our study in the list!!

[Annals of Oncology @Annals_Oncology]

Just out, a report from the ARCAGEN study of rare GI malignancies in the @EORTC - SPECTA molecular profiling 🧬🎯program:
🔹3.5% TMB-H & 2.3% MSI-H
🔹Liquid biopsies 🩸 for 75% of iCCA
🔹9 patients (10.3%) with treatment adaptation
https://t.co/vULwH4tJgz
@DrAngelaLamarca

[Gut Journal @Gut_BMJ]

#GUTPodcast with @Areche_M on "Next-generation sequencing of bile cell-free DNA for the early detection of pts with malignant biliary strictures" via https://t.co/ORf2ECvObP
Paper: https://t.co/r41tPUIeNC
@LennyNelson15 @CUBEROlab @pottoberasain @daniel_oyon @AESPANC @juanvila

[Gut Journal @Gut_BMJ]

Plaza del Castillo square in Pamplona, Spain. @Areche_M et al report on next-generation sequencing of bile cell-free DNA for the early detection of malignant biliary strictures via https://t.co/r41tPUIeNC

@daniel_oyon @LennyNelson15 @CUBEROlab @pottoberasain @AESPANC @juanjvila

[Daniel Oyón @daniel_oyon]

Very proud of our paper and for seeing the Plaza del Castillo square in Pamplona, my hometown, as the cover of the new issue of GUT.

Next-generation sequencing of bile cell-free DNA for the early detection of patients with malignant biliary strictures https://t.co/wWPdzBHYj7

[Jesus Urman @JesusUrman]

Enhorabuena Pablo por tu trabajo

[Pilar Nos @pilarnos]

Bilemut. La biopsia líquida va a ser clave en el futuro. Datos en colangiocarcinoma. Resultados preliminares en @aegastro ademas identifican tumores susceptibles de terapia génica.

[Medena Navarra @MedenaColegio]

María Rullán Iriarte, segundo premio del II Certamen de Casos Clínicos de @MedenaColegio
http://t.co/xbM8x0ODPF

[Medena Navarra @MedenaColegio]

¿Qué ofrece @MedenaColegio a los #médicos jóvenes? Nos lo cuenta María Rullán en editorial de #revistapanacea https://t.co/1FpH1P9DP8

[Medena Navarra @MedenaColegio]

El Colegio de Médicos de Navarra entrega los premios del V Certamen de Casos Clínicos para Médicos Internos Residentes.
Cristina Gómez, Inés Esparragosa y María Rullán, ganadoras del primer, segundo y tercer premio. Premio al mejor póster para Sheila Lacarra.
@MedenaColegio

[SEED @SEEDendoscopia]

La exposición de los casos clínicos 📚 por parte de #CarlosMármol, #JesúsGotor, #MaríaRullán y #FrancescBas centra la actividad de esta tarde del #CursoR4SEED. Las preguntas incluidas en las presentaciones logran un alto quorum en las respuestas ✅ #gastrointestinalendoscopy